These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 25848132

  • 1. Effects of Pregnane X Receptor Genetic Polymorphisms on Stable Warfarin Doses.
    Moon JY, Chang BC, Lee KE, Bang JS, Gwak HS.
    J Cardiovasc Pharmacol Ther; 2015 Nov; 20(6):532-8. PubMed ID: 25848132
    [Abstract] [Full Text] [Related]

  • 2. Influence of UDP-Glucuronosyltransferase Polymorphisms on Stable Warfarin Doses in Patients with Mechanical Cardiac Valves.
    An SH, Chang BC, Lee KE, Gwak HS.
    Cardiovasc Ther; 2015 Dec; 33(6):324-8. PubMed ID: 26223945
    [Abstract] [Full Text] [Related]

  • 3. Combined effects of hepatocyte nuclear factor 4α and constitutive androstane receptor on stable warfarin doses.
    Moon JY, Lee KE, Chang BC, Jeong E, Jeong H, Gwak HS.
    Pharmacogenet Genomics; 2015 Jan; 25(1):38-40. PubMed ID: 25356900
    [Abstract] [Full Text] [Related]

  • 4. Polymorphisms of vitamin K-related genes (EPHX1 and VKORC1L1) and stable warfarin doses.
    Chung JE, Lee KE, Chang BC, Gwak HS.
    Gene; 2018 Jan 30; 641():68-73. PubMed ID: 29054760
    [Abstract] [Full Text] [Related]

  • 5. Influence of NR3C1 and VDR polymorphisms on stable warfarin dose in patients with mechanical cardiac valves.
    Lee KE, Chung JE, Yi B, Cho YJ, Kim HJ, Lee GY, Kim JH, Chang BC, Gwak HS.
    Int J Cardiol; 2017 Jun 01; 236():393-397. PubMed ID: 28262345
    [Abstract] [Full Text] [Related]

  • 6. Effects of single nucleotide polymorphisms in c-Myc on stable warfarin doses in patients with cardiac valve replacements.
    Lee KE, Chang BC, Park S, Gwak HS.
    Pharmacogenomics; 2015 Jun 01; 16(10):1101-8. PubMed ID: 26249541
    [Abstract] [Full Text] [Related]

  • 7. [Influence of warfarin related genes and non- genetic factors on administrative dose in Shanghai area].
    Zhuang W, Wu D, Wang Z.
    Zhonghua Xue Ye Xue Za Zhi; 2014 Jan 01; 35(1):13-7. PubMed ID: 24602724
    [Abstract] [Full Text] [Related]

  • 8. The impact of non-genetic and genetic factors on a stable warfarin dose in Thai patients.
    Wattanachai N, Kaewmoongkun S, Pussadhamma B, Makarawate P, Wongvipaporn C, Kiatchoosakun S, Vannaprasaht S, Tassaneeyakul W.
    Eur J Clin Pharmacol; 2017 Aug 01; 73(8):973-980. PubMed ID: 28550460
    [Abstract] [Full Text] [Related]

  • 9. Effects of NAD(P)H quinone oxidoreductase 1 polymorphisms on stable warfarin doses in Korean patients with mechanical cardiac valves.
    Chung JE, Chang BC, Lee KE, Kim JH, Gwak HS.
    Eur J Clin Pharmacol; 2015 Oct 01; 71(10):1229-36. PubMed ID: 26257249
    [Abstract] [Full Text] [Related]

  • 10. Association between the CYP2C9 polymorphism and the drug metabolism phenotype.
    Topić E, Stefanović M, Samardzija M.
    Clin Chem Lab Med; 2004 Jan 01; 42(1):72-8. PubMed ID: 15061384
    [Abstract] [Full Text] [Related]

  • 11. Association of Genetic Polymorphisms in the VKORC1 and CYP2C9 Genes with Warfarin Dosage in a Group of Kuwaiti Individuals.
    Alrashid MH, Al-Serri A, Alshemmari SH, Koshi P, Al-Bustan SA.
    Mol Diagn Ther; 2016 Apr 01; 20(2):183-90. PubMed ID: 26940072
    [Abstract] [Full Text] [Related]

  • 12. CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population.
    Borgiani P, Ciccacci C, Forte V, Sirianni E, Novelli L, Bramanti P, Novelli G.
    Pharmacogenomics; 2009 Feb 01; 10(2):261-6. PubMed ID: 19207028
    [Abstract] [Full Text] [Related]

  • 13. Association between CYP2C9 and VKORC1 genetic polymorphisms and efficacy and safety of warfarin in Chinese patients.
    Zhang S, Zhao M, Zhong S, Niu J, Zhou L, Zhu B, Su H, Cao W, Xing Q, Yan H, Han X, Fu Q, Li Q, Chen L, Yang F, Zhang N, Wu H, He L, Qin S.
    Pharmacogenet Genomics; 2024 Jun 01; 34(4):105-116. PubMed ID: 38470454
    [Abstract] [Full Text] [Related]

  • 14. Factors affecting the interindividual variability of warfarin dose requirement in adult Korean patients.
    Cho HJ, Sohn KH, Park HM, Lee KH, Choi B, Kim S, Kim JS, On YK, Chun MR, Kim HJ, Kim JW, Lee SY.
    Pharmacogenomics; 2007 Apr 01; 8(4):329-37. PubMed ID: 17391071
    [Abstract] [Full Text] [Related]

  • 15. Influence of CYP4F2 rs2108622 (V433M) on warfarin dose requirement in Asian patients.
    Singh O, Sandanaraj E, Subramanian K, Lee LH, Chowbay B.
    Drug Metab Pharmacokinet; 2011 Apr 01; 26(2):130-6. PubMed ID: 21084764
    [Abstract] [Full Text] [Related]

  • 16. Lack of association of single-nucleotide polymorphisms in pregnane X receptor, hepatic nuclear factor 4alpha, and constitutive androstane receptor with docetaxel pharmacokinetics.
    Tham LS, Holford NH, Hor SY, Tan T, Wang L, Lim RC, Lee HS, Lee SC, Goh BC.
    Clin Cancer Res; 2007 Dec 01; 13(23):7126-32. PubMed ID: 18056193
    [Abstract] [Full Text] [Related]

  • 17. Pregnane X receptor and hepatocyte nuclear factor 4α polymorphisms are cooperatively associated with carbamazepine autoinduction.
    Saruwatari J, Yoshida S, Tsuda Y, Okada Y, Ogusu N, Yoshida K, Oniki K, Yasui-Furukori N, Kaneko S, Ishitsu T, Nakagawa K.
    Pharmacogenet Genomics; 2014 Mar 01; 24(3):162-71. PubMed ID: 24384557
    [Abstract] [Full Text] [Related]

  • 18. CYP2C9 genotypes and dose requirements during the induction phase of oral anticoagulant therapy.
    Peyvandi F, Spreafico M, Siboni SM, Moia M, Mannucci PM.
    Clin Pharmacol Ther; 2004 Mar 01; 75(3):198-203. PubMed ID: 15001971
    [Abstract] [Full Text] [Related]

  • 19. Effect of genetic factors on the interindividual variability of warfarin dosage requirements in Japanese patients after adjusting for renal function.
    Nishiba H, Nagamine A, Yashima H, Takahashi Y, Higuchi Y, Sekizaki N, Nakamura H, Araki T, Takama N, Koitabashi N, Nakajima T, Kaneko Y, Ohyama Y, Yokoyama T, Imai K, Kurabayashi M, Yamamoto K, Obayashi K.
    Pharmazie; 2024 Aug 01; 79(7):173-177. PubMed ID: 39152554
    [Abstract] [Full Text] [Related]

  • 20. The nuclear receptors constitutive androstane receptor and pregnane X receptor cross-talk with hepatic nuclear factor 4alpha to synergistically activate the human CYP2C9 promoter.
    Chen Y, Kissling G, Negishi M, Goldstein JA.
    J Pharmacol Exp Ther; 2005 Sep 01; 314(3):1125-33. PubMed ID: 15919766
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.